Get the Stockscreener App
1.82
0.00%
0.00
After Hours:
1.82
Curis Inc stock is traded at $1.82, with a volume of 81,009.
It is up +0.00% in the last 24 hours and up +10.30% over the past month.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
See More
Previous Close:
$1.82
Open:
$1.83
24h Volume:
81,009
Relative Volume:
0.76
Market Cap:
$22.75M
Revenue:
$10.16M
Net Income/Loss:
$-47.57M
P/E Ratio:
-0.2209
EPS:
-8.24
Net Cash Flow:
$-42.73M
1W Performance:
+8.33%
1M Performance:
+10.30%
6M Performance:
-30.80%
1Y Performance:
-63.53%
1-Day Range:
$1.79
$1.93
1-Week Range:
$1.655
$1.95
52-Week Range:
$1.02
$6.44
Curis Inc Stock (CRIS) Company Profile
Name
Curis Inc
Sector
Industry
Phone
617-503-6500
Address
128 SPRING STREET, LEXINGTON, MA
Compare CRIS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CRIS
Curis Inc
|
1.82 | 22.37M | 10.16M | -47.57M | -42.73M | -8.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Curis Inc Stock (CRIS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-19-25 | Resumed | H.C. Wainwright | Buy |
| Nov-17-23 | Initiated | Truist | Buy |
| Apr-04-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Oct-13-21 | Initiated | Raymond James | Outperform |
| Mar-25-21 | Initiated | B. Riley Securities | Buy |
| Jul-29-20 | Initiated | Laidlaw | Buy |
| Jul-17-20 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-24-17 | Initiated | Guggenheim | Buy |
| Mar-02-16 | Initiated | Sun Trust Rbsn Humphrey | Buy |
| Nov-09-15 | Reiterated | ROTH Capital | Buy |
| Aug-11-15 | Initiated | FBR Capital | Outperform |
| Jan-22-15 | Reiterated | Oppenheimer | Outperform |
| Jan-21-15 | Reiterated | ROTH Capital | Buy |
| May-09-14 | Reiterated | Oppenheimer | Outperform |
| Oct-02-13 | Initiated | Robert W. Baird | Outperform |
| Sep-30-13 | Initiated | Chardan Capital Markets | Buy |
| Nov-14-12 | Initiated | Stifel Nicolaus | Hold |
| Jan-31-12 | Reiterated | Brean Murray | Buy |
| Jan-31-12 | Reiterated | Summer Street Research | Buy |
| Dec-09-11 | Initiated | Oppenheimer | Outperform |
| Oct-06-11 | Initiated | Summer Street Research | Buy |
| Sep-22-11 | Initiated | MLV Capital | Buy |
| Mar-21-11 | Reiterated | Brean Murray | Buy |
| Feb-26-10 | Reiterated | Roth Capital | Buy |
| Jan-07-10 | Initiated | Roth Capital | Buy |
View All
Curis Inc Stock (CRIS) Latest News
Will Curis Inc. benefit from macro trendsEarnings Risk Report & Precise Trade Entry Recommendations - Newser
Market reaction to Curis Inc.’s recent newsNew Guidance & Free Accurate Trade Setup Notifications - Newser
How to manage a losing position in Curis Inc.Portfolio Risk Report & Free Fast Gain Swing Trade Alerts - Newser
Curis Inc. stock trend outlook and recovery pathWeekly Market Summary & Fast Entry and Exit Trade Plans - Newser
Can Curis Inc. hit a new high this month2025 Winners & Losers & Free Safe Capital Growth Stock Tips - Newser
Is it too late to sell Curis Inc.Market Movers & Proven Capital Preservation Methods - Newser
Can technical indicators confirm Curis Inc.’s reversalMarket Trend Review & Reliable Volume Spike Alerts - Newser
Short interest data insights for Curis Inc.July 2025 Drop Watch & Daily Stock Trend Reports - Newser
Can volume confirm reversal in Curis Inc.July 2025 Levels & Weekly Momentum Stock Picks - Newser
When is the best time to exit Curis Inc.Price Action & Stepwise Entry/Exit Trade Alerts - Newser
Reversal indicators forming on Curis Inc. stockQuarterly Earnings Summary & AI Powered Buy and Sell Recommendations - Newser
Is Curis Inc. stock reversal real or fakeMarket Activity Summary & Daily Profit Maximizing Trade Tips - Newser
Can volume confirm reversal in Curis IncQuarterly Trade Review & High Conviction Buy Zone Alerts - Newser
Signal strength of Curis Inc. stock in tech scannersJuly 2025 Selloffs & Smart Investment Allocation Insights - Newser
Curis Inc. stock chart pattern explainedJuly 2025 Retail & Verified Short-Term Plans - Newser
Published on: 2025-09-11 16:31:55 - Newser
Measuring Curis Inc.’s beta against major indicesIPO Watch & Reliable Breakout Forecasts - Newser
What earnings revisions data tells us about Curis Inc.Portfolio Return Summary & High Conviction Investment Ideas - Newser
Volatility clustering patterns for Curis Inc.Trade Signal Summary & Daily Chart Pattern Signal Reports - Newser
What institutional flow reveals about Curis Inc.July 2025 Update & AI Powered Market Entry Strategies - Newser
Tick level data insight on Curis Inc. volatilityQuarterly Profit Summary & Daily Volume Surge Signals - Newser
Transcript : Curis, Inc. Presents at Cantor Global Healthcare Conference 2025, Sep-05-2025 09 - MarketScreener
Curis at H.C. Wainwright: Emiflucertib’s Therapeutic Promise - Investing.com
Curis at H.C. Wainwright: Emiflucertib's Therapeutic Promise - Investing.com
Will Curis Inc. stock benefit from interest rate changesJuly 2025 Snapshot & AI Enhanced Market Trend Forecasts - Newser
Is Curis Inc. forming a bottoming base2025 Analyst Calls & Free Real-Time Market Sentiment Alerts - Newser
Visualizing Curis Inc. stock with heatmaps2025 Market Sentiment & Daily Price Action Insights - Newser
What moving averages say about Curis Inc.Market Trend Review & Safe Capital Preservation Plans - Newser
What does recent volatility data suggest for Curis Inc.2025 Breakouts & Breakdowns & Verified Momentum Stock Alerts - Newser
Should you hold or exit Curis Inc. nowTrade Exit Summary & Weekly High Potential Stock Alerts - Newser
Curis Inc Stock (CRIS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):